Trough to peak ratio : current status and applicability : Trough to peak ratiosELLIOTT, H. L.Journal of human hypertension. 1998, Vol 12, Num 1, pp 55-59, issn 0950-9240Article

Angiotensin II antagonists : efficacy, duration of action, comparison with other drugsELLIOTT, H. L.Journal of human hypertension. 1998, Vol 12, Num 5, pp 271-274, issn 0950-9240Conference Paper

The case for alpha₁-adrenocepter antagonists as first-line antihypertensive agentsELLIOTT, H. L.Journal of human hypertension. 1991, Vol 5, Num 4, pp 309-311, issn 0950-9240, 3 p.Article

24-hour blood pressure control: its relevance to cardiovascular outcomes and the importance of long-acting antihypertensive drugsELLIOTT, H. L.Journal of human hypertension. 2004, Vol 18, Num 8, pp 539-543, issn 0950-9240, 5 p.Conference Paper

Trandolapril does not improve insulin sensitivity in patients with hypertension and type 2 diabetes : A double-blind, placebo-controlled crossover trialPETRIE, J. R; MORRIS, A. D; UEDA, S et al.The Journal of clinical endocrinology and metabolism. 2000, Vol 85, Num 5, pp 1882-1889, issn 0021-972XArticle

Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular diseaseCLELAND, S. J; SATTAR, N; PETRIE, J. R et al.Clinical science (1979). 2000, Vol 98, Num 5, pp 531-535, issn 0143-5221Article

Renal effects of amlodipine in normotensive renal transplant recipientsRAMAN, G. V; FEEHALLY, J; COATES, R. A et al.Nephrology, dialysis, transplantation (Print). 1999, Vol 14, Num 2, pp 384-388, issn 0931-0509Article

ACE inhibition in chronic renal failure and in the treatment of diabetic nephropathy : Focus on spiraprilJARDINE, A. G; ELLIOTT, H. L.Journal of cardiovascular pharmacology. Supplement. 1999, Vol 34, Num 1, pp S31-S34Conference Paper

Dietary sodium restriction impairs insulin sensitivity in noninsulin-dependent diabetes mellitusPETRIE, J. R; MORRIS, A. D; MINAMISAWA, K et al.The Journal of clinical endocrinology and metabolism. 1998, Vol 83, Num 5, pp 1552-1557, issn 0021-972XArticle

Renal and haemodynamic effects of amlodipine and nifedipine in hypertensive renal transplant recipientsVENKAT-RAMAN, G; FEEHALLY, J; ELLIOTT, H. L et al.Nephrology, dialysis, transplantation (Print). 1998, Vol 13, Num 10, pp 2612-2616, issn 0931-0509Article

Analysis of trough:peak ratio and the assessment of anti-hypertensive drug actionELLIOTT, H. L; MEREDITH, P. A.Journal of human hypertension. 1995, Vol 9, Num 6, pp 423-427, issn 0950-9240Conference Paper

The pharmacodynamics and pharmacokinetics of the combination of nifedipine and doxazosinDONNELLY, R; ELLIOTT, H. L; MEREDITH, P. A et al.European journal of clinical pharmacology. 1993, Vol 44, Num 3, pp 279-282, issn 0031-6970Article

Long-acting calcium antagonists : amlodipine versus nifedipine gastrointestinal therapeutic system (GITS)UEDA, S; MEREDITH, P. A; HOWIE, C. A et al.Journal of hypertension. Supplement. 1993, Vol 11, Num 5, pp S332-S333, issn 0952-1178Conference Paper

Clinical pharmacokinetics of amlodipineMEREDITH, P. A; ELLIOTT, H. L.Clinical pharmacokinetics. 1992, Vol 22, Num 1, pp 22-31, issn 0312-5963Article

A dose-ranging of UK-87,798, a novel class III anti-arrhythmic agent, in normal volunteersGEMMILL, J. D; HOWIE, C. A; MEREDITH, P. A et al.British journal of clinical pharmacology. 1991, Vol 32, Num 4, pp 429-432, issn 0306-5251Article

Inhibitory effect of uraemia on the hepatic clearance and metabolism of nicardipineAHMED, J. H; GRANT, A. C; RODGER, R. S. C et al.British journal of clinical pharmacology. 1991, Vol 32, Num 1, pp 57-62, issn 0306-5251, 6 p.Article

Dose-response clarification in early drug developmentMEREDITH, P. A; ELLIOTT, H. L; DONNELLY, R et al.Journal of hypertension. 1991, Vol 9, pp S356-S357, issn 0263-6352, SUP6Conference Paper

The effects of age on the pharmacokinetics, antihypertensive efficacy and general tolerability of dilevalolMACPHEE, G. J. A; HOWIE, C. A; MEREDITH, P. A et al.British journal of clinical pharmacology. 1991, Vol 32, Num 5, pp 591-597, issn 0306-5251Conference Paper

Nifedipine: individual responses and concentration-effect relationshipsDONNELLY, R; ELLIOTT, H. L; MEREDITH, P. A et al.Hypertension (Dallas, Tex. 1979). 1988, Vol 12, Num 4, pp 443-449, issn 0194-911XArticle

Desensitization of platelet α₂-adrenoceptors after short term infusions of adrenoceptor agonist in manJONES, C. R; GIEMBCYZ, M; HAMILTON, C. A et al.Clinical science (1979). 1986, Vol 70, Num 2, pp 147-153, issn 0143-5221Article

Disopyramide in acute myocardial infarction: problems with changing pharmacokineticsELLIOTT, H. L; THOMSON, A. H; BRYSON, S. M et al.European journal of clinical pharmacology. 1986, Vol 30, Num 3, pp 345-347, issn 0031-6970Article

Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studiesJONES, C. R; PASANISI, F; ELLIOTT, H. L et al.British journal of clinical pharmacology. 1985, Vol 20, pp 191-196, issn 0306-5251Article

The effect of cimetidine on the pharmacokinetics, pharmacodynamics and alpha₁-adrenoceptor responsiveness of trimazosin in manVINCENT, J; ELLIOTT, H. L; MEREDITH, P. A et al.European journal of clinical pharmacology. 1985, Vol 29, Num 3, pp 301-306, issn 0031-6970Article

Comparison of the clinical pharmacokinetics and concentration-effect relationships for medroxalol and labetalolELLIOTT, H. L; MEREDITH, P. A; SUMNER, D. J et al.British journal of clinical pharmacology. 1984, Vol 17, Num 5, pp 573-578, issn 0306-5251Article

Doxazosin, and α₁-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in manVINCENT, J; ELLIOTT, H. L; MEREDITH, P. A et al.British journal of clinical pharmacology. 1983, Vol 15, Num 6, pp 719-725, issn 0306-5251Article